Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
3446.T
HOLDREMOVEJTEC Corporation · Healthcare · Japan · $67M · Avg Vol: $488K/d
Niche healthcare equipment provider with insufficient scale and no alignment with our high-conviction macro themes.
COMPANY DESCRIPTION
JTEC Corporation designs and manufactures ultra-high-precision optical components, most notably automated X-ray mirrors used in synchrotron radiation facilities worldwide. The company possesses world-leading, nanometer-level surface processing technology, giving it a near-monopoly position in this highly specialized scientific research niche. Its products are critical for advanced materials science, semiconductor development, and life sciences research globally.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 7M | 12M | 13M | — | 32.2% |
| EPS | -0.03 | 0.25 | 0.21 | 0.06 | -49.7% |
| Shares | 6M | 6M | 6M | 6M | +0.4% |
| Debt | 6M | 4M | 4M | 3M | -18.0% |
| Equity | 14M | 14M | 15M | 17M | 6.1% |
| Op CF | — | 2M | 1M | 391,684 | -53.0% |
| Inv CF | — | -828,943 | -529,793 | -1M | — |
| Fin CF | — | -2M | -472,039 | -472,176 | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 3446.T are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 3446.T | JTEC Corporation(you) | $67M | 47 | HOLD |
| 7702.T | JMS Co.,Ltd. | $66M | 62 | HOLD |
| 7775.T | Daiken Medical Co., Ltd. | $77M | 77 | BUY |
| 3154.T | Medius Holdings Co., Ltd. | $117M | 71 | BUY |
| 4556.T | KAINOS Laboratories, Inc. | $62M | 84 | STRONG BUY |
| 7743.T | SEED Co.,Ltd. | $92M | 81 | STRONG BUY |
| 197A.T | TAUNS LABORATORIES INC. | $326M | 67 | BUY |
| 262A.T | INTERMESTIC INC | $399M | 66 | BUY |
| 368A.T | KITAZATO CORPORATION | $294M | 86 | STRONG BUY |
| 5889.T | JAPAN EYEWEAR HOLDINGS CO LTD | $311M | 87 | STRONG BUY |
Peer medians: ROE 8.4% · P/E 15.5x · Gross margin 47.8%